Karin Eastham

Karin Eastham has spent their career in the healthcare industry, working with leading companies to improve patient care. Karin is currently the Director at Veracyte, a position they have held since December 2015. Prior to joining Veracyte, Karin served on the Board of Directors for Nektar Therapeutics, AltheaDx, and MorphoSys AG. Karin also served as Co-Chair of Women Corporate Directors from 2013 to 2014. Karin has a deep commitment to improving healthcare and has been recognized for their work in this area. In 2019, they were named one of the 100 Most Influential People in Healthcare by Modern Healthcare.

Karin Eastham has an MBA in Finance from the Indiana University - Kelley School of Business and a B.S. in Accounting from the same school.